Skip to main navigation Skip to search Skip to main content

Advancing the quantitative understanding of adverse outcome pathways: current status, methodologies, and future directions

  • University of Seoul

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

An adverse outcome pathway (AOP) framework maps the sequence of events leading to adverse outcomes from chemical exposures, providing a mechanistic understanding often absent in traditional methods. The quantitative AOP (qAOP) advances AOP by integrating quantitative data and mathematical modeling, thereby providing a more precise comprehension of relationships between molecular initiating events, key events, and adverse outcomes. This review critically examines three primary methodologies: systems toxicology, regression modeling, and Bayesian network modeling, highlighting their strengths, limitations, and specific data requirements within toxicology. Through an analysis of current methodologies and challenges, this review emphasizes the integration of experimental and computational approaches to elucidate key event relationships and proposes strategies for overcoming limitations through standardized protocols and advanced computational tools. By outlining future research directions and the potential of qAOPs to transform chemical risk assessment, this review aims to contribute to the advancement of regulatory science and the protection of public health and the environment.

Original languageEnglish
Pages (from-to)614-623
Number of pages10
JournalEnvironmental Toxicology and Chemistry
Volume44
Issue number3
DOIs
StatePublished - 1 Mar 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bayesian network
  • key event relationship
  • quantitative adverse outcome pathway
  • regression model
  • systems biology

Fingerprint

Dive into the research topics of 'Advancing the quantitative understanding of adverse outcome pathways: current status, methodologies, and future directions'. Together they form a unique fingerprint.

Cite this